Lisata Therapeutics Inc LSTA

US Biotechnology

$1.58 ▲ +5.33% (+$0.08)

⬆️ Above Yest. High 🎈 Low Float

Open $1.54

Prev Close $1.50

Day Range $1.49 – $1.58

52W Range $0.99 – $5.07

Market Cap $14.24M

Beta 0.99

EPS (TTM) $-1.14

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1995-11-03
Shares Out.	9,110,000
Website	lisata.com/ ↗
Phone	19082292590
Employees	21
Revenue	$0
Gross Profit	$0
Net Income	-$2.9M
Free Cash Flow	-$12.3M
Total Assets	$11.0M
Total Liabilities	$3.0M
Equity	$8.0M

About Lisata Therapeutics Inc

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Lisata Therapeutics Inc is a publicly traded company under the ticker symbol LSTA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.